← Back to news
S

Seeking Alpha: News

Altimmune outlines PERFORMA Phase III MASH start in 2H 2026 and cash runway to 2029 52-week readout

S

Copa Holdings GAAP EPS of $5.16 beats by $1.20, revenue of $1.05B beats by $20M

B

Teekay Tankers declares $0.25 regular and $1 special dividend

B

Banco Santander GAAP EPS of -C$0.06

B

OpenAI supports US-led global AI governance framework with China as a member

B

Yum! Brands declares $0.75 dividend

B

Northern Oil & Gas declares $0.45 dividend

B

Independence Realty Trust raises dividend by 6% to $0.18

B

Thursday’s Economic Calendar

B

Aeluma outlines $4.2M-$4.6M FY2026 revenue guidance amid government contract timing delays

B

Shoulder Innovations forecasts $65M-$68M 2026 net revenue as it raises guidance following Q1 growth

S

Worksport reaffirms $35M-$42M fiscal 2026 revenue guidance while shifting to annual guidance updates

S

Caliber reaffirms 2026 revenue of $18M-$22M while positioning tokenization and note conversions to support liquidity

S

Omeros expects YARTEMLEA to drive company-wide positive cash flow within 18 months as early TA-TMA uptake builds

S

CXApp outlines June CXAI 2.0 rollout while targeting gross margin stabilization in the 80% range

B

Cisco outlines ~$9B FY 2026 hyperscaler AI infrastructure orders while guiding Q4 revenue to $16.7B-$16.9B

B

Precigen anticipates funding through cash flow breakeven by end of 2026 as PAPZIMEOS launch scales

S

Similarweb outlines $307M-$315M 2026 revenue outlook as CEO transition is expected by mid-2027

S

Energous outlines plan to complete installation at approximately 35 facilities in 2026 while holding off additional ATM usage this year

S

StubHub reiterates 2026 outlook for $9.9B-$10.1B GMS and $400M-$420M adjusted EBITDA as margins expand

S

Motorsport Games outlines plan to share 2027+ growth roadmap in Q3, following $3.7M share repurchase

S

Aytu outlines $6M-$7M quarterly sales and marketing spend range as EXXUA scripts rise to over 920 in April

S

Inovio outlines cash runway into Q1 2027 as INO-3107 targets October 30, 2026 PDUFA date

S

Planet 13 outlines Schedule III tax shift for ~40% of Q1 revenue as Clark County hemp rules start mid-July

S

Longeveron anticipates August 2026 ELPIS II readout while shifting to an asset-light partnering model

B

QT Imaging outlines ~$39M 2026 revenue outlook as AMA CPT code takes effect January 1, 2027

B

ClearPoint forecasts $52m-$56m 2026 revenue range as IRRAflow could be cash neutral as early as 2027

S

Insight Molecular Diagnostics expects about $0.25M Q2 2026 revenue while projecting second-quarter cash burn above $9M

S

House lawmakers pass year-round nationwide sales of higher-ethanol gasoline

S

HF Sinclair terminates CFO Atanasov, a day after CEO Go departs

S

Lulu’s anticipates positive adjusted EBITDA in 2026 with $2.0M-$2.5M capex plan

S

Oil turns lower but still above $100 as OPEC cuts 2026 global demand forecast

S

Fluent expects Commerce Media gross margin to return to the mid-20s in 2026 as it expands beyond retail

B

Journey Medical signals positive EBITDA for remainder of 2026 as it plans to add up to 5 sales professionals

B

Cytosorbents targets operating cash flow breakeven in 2H 2026 while planning DrugSorb-ATR de novo submission in late 2026/early 2027

B

USA Rare Earth outlines 600 metric tons per annum magnet run rate by year-end while finalizing $1.6B Department of Commerce documentation

B

Usio reiterates 10% to 12% 2026 revenue growth as PostCredit targets launch in the upcoming months

S

Talphera targets Niyad PMA filing in 2026 and potential approval in 2027 as NEPHRO enrollment surpasses 50%

S

Marchex anticipates Q2 adjusted EBITDA of $1.6M-$1.8M as Archenia deal targets July close

S

Ascend outlines 2% to 3% Q2 top line growth while targeting at least 60 stores by year-end

S

Seer reaffirms $16M-$18M 2026 revenue guidance amid new patent suit and commercial leadership hire

S

Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve

S

What’s next for Amazon after record-breaking quarter?

S

Identiv anticipates Q2 sales of $5.4M-$6.0M as IFCO mass production is planned for Q4

S

Seastar Medical targets about $2M 2026 QUELIMMUNE revenue while aiming to finish NEUTRALIZE-AKI enrollment by end of 2026

S

Wrap Technologies targets 100% 2026 revenue growth as Q1 product sales rise 186%

S

Leslie’s reiterates FY2026 sales $1.1B-$1.25B and adjusted EBITDA $55M-$75M as Price Drop drives traffic

B

Power Solutions International CEO Xykis resigns; Li tapped as interim CEO

B

Oklo SEC filing post-Q1: $1B ATM equity raise tied to Meta, NVIDIA AI demand

B

Kodiak Gas Services launches $750M public offering of common stock

B